Novel therapies for constipation

doi:10.3748/wjg.v19.i45.8247

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 19, Issue 45

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6519)

All Articles published online

The chart showing PDF series, HTML series, Tables (1-2) series.

Item

Count

PDF

515

HTML

4326

Tables (1-2)

121

Sum=4962

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

881

Download

676

Sum=1557

Dec 7, 2013 (publication date) through Apr 24, 2024

Times Cited of This Article

Times Cited (24)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Gastroenterol. Dec 7, 2013; 19(45): 8247-8251
Published online Dec 7, 2013. doi: 10.3748/wjg.v19.i45.8247

Novel therapies for constipation

Sreedhari Thayalasekeran, Hani Ali, Her-Hsin Tsai

Sreedhari Thayalasekeran, Hani Ali, Her-Hsin Tsai, Department of Gastroenterology, Castle Hill Hospital, Cottingham HU165JQ, United Kingdom

Author contributions: Thayalasekeran S, Ali H and Tsai HH contributed equally to this work.

Correspondence to: Her-Hsin Tsai, MD, Department of Gastroenterology, Castle Hill Hospital, HEY NHS Trust, Cottingham HU165JQ, United Kingdom. hhtsai@doctors.org.uk

Telephone: +44-14-82875875 Fax: +44-14-82875875

Received: June 24, 2013
Revised: September 13, 2013
Accepted: October 13, 2013
Published online: December 7, 2013

Core Tip

Core tip: When standard laxatives fail in the management of constipation, licensed medication linaclotide and prucalopride show useful efficacy in clinical trials.